Gene Expression Profiles to Categorize Wilms Tumors

Completed

Conditions studied: Recurrent Wilms Tumor and Other Childhood Kidney Tumors, Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor, Stage IV Wilms Tumor, Stage V Wilms Tumor

In brief

This laboratory study is using gene expression profiling to identify different categories of Wilms tumors. Studying the genes expressed in samples of tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer.

Key facts

Study ID

NCT00897637

Run by

Children's Oncology Group

People needed

600

Starts

2004-02-01

Last updated by the study team

2016-05-19

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Specimens from patients previously enrolled as "On Study" or "Followed Biology Only" on protocol NWTSG-5 (COG-Q9401)
• Study follow-up data for disease status available
• National Wilms Tumor Study Group/Children's Oncology Group pathology review showing "favorable" histology
• Sufficient biology samples available without using biology bank reserves

Where it is running

• Children's Oncology Group — Arcadia, California, United States
• Saint Mary's Hospital — West Palm Beach, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.